🟢 Viking Therapeutics is trading 4.11% up today amid stronger biotech sentiment

Viking Therapeutics is trading at $26.08, up 4.11%, amid stronger biotech-sector sentiment.

• No clear Viking Therapeutics-specific catalyst surfaced for October 20, 2026.
• Sector context showed XBI up 2.10%, amid Merck KGaA’s agreement to acquire Silence Therapeutics.
• Reuters reported the deal at approximately $1.3 billion; it did not link the transaction directly to Viking Therapeutics shares.